Avanafil – (330784-47-9)

Avanafil is a selective phosphodiesterase-5 (PDE-5) inhibitor for the treatment of erectile dysfunction (ED), by inhibiting the PDE-5 enzyme, which is primarily found in the corpus cavernosum of the penis.

Avanafil is known for its rapid onset of action, with effects observed as early as 15 minutes after administration. Common adverse effects include headache, flushing, nasopharyngitis, nasal congestion, and back pain.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Avanafil is a selective phosphodiesterase-5 (PDE-5) inhibitor for the treatment of erectile dysfunction (ED), by inhibiting the PDE-5 enzyme, which is primarily found in the corpus cavernosum of the penis.

Avanafil is known for its rapid onset of action, with effects observed as early as 15 minutes after administration. Common adverse effects include headache, flushing, nasopharyngitis, nasal congestion, and back pain.

The above informationis displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
Sources:
https://en.wikipedia.org/wiki/Avanafil
https://pubchem.ncbi.nlm.nih.gov/compound/9869929
https://www.medchemexpress.com/Avanafil.html
https://www.medkoo.com/products/6434
https://www.mayoclinic.org/drugs-supplements/avanafil-oral-route/description/drg-20075594
https://www.sciencedirect.com/topics/veterinary-science-and-veterinary-medicine/avanafil
Other Names

Avanafil, STENDRA, Spedra, TA-1790

IUPAC Name

4-[(3-chloro-4-methoxyphenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide

CAS

330784-47-9

Molecular Weight

483.9

Molecular Formula

C23H26ClN7O3

SMILES

COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCC[C@H]4CO)Cl

No products in the cart.